On August 31, 2022 Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, reported that the company will participate in two upcoming investor conferences (Press release, Revolution Medicines, AUG 31, 2022, View Source [SID1234618818]). Mark A. Goldsmith, M.D., Ph.D., chief executive officer and chairman of Revolution Medicines, will be the featured speaker in fireside chats at the 2022 Wells Fargo Healthcare Conference and the H.C. Wainwright 24th Annual Global Investment Conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of these events are as follows:

2022 Wells Fargo Healthcare Conference
Conference Date: September 7-9, 2022
Fireside Chat Time/Date: 3:45 – 4:15 p.m. Eastern on Thursday, September 8, 2022
Format: In-person conference located at Encore Boston Harbor
H.C. Wainwright 24th Annual Global Investment Conference
Conference Date: September 12-14, 2022
Fireside Chat Time/Date: 7:00 a.m. Eastern on Monday, September 12, 2022
Format: Hybrid event (in-person and virtual); webcast available
A webcast of the H.C. Wainwright fireside chat can be accessed at: View Source An archived replay of the webcast will be available on the investors section of the company’s website for at least 14 days following the event.